Abstract
Synchronous gastric and pancreatic cancers represent a very rare association. The role of tomodensitometry, endoscopic ultrasound and histology is primordial to differentiate between double tumors, local extension or metastasis. We report in our paper two cases of synchronous gastric and pancreatic cancers treated with Folforinox. Then, we discuss the risk factors, the diagnostic methods, the treatment modalities and the prognosis of these rare double cancers.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.
MeSH terms
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / pathology*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Camptothecin / administration & dosage
-
Camptothecin / analogs & derivatives
-
Fluorouracil / administration & dosage
-
Humans
-
Irinotecan
-
Male
-
Middle Aged
-
Neoplasms, Multiple Primary / drug therapy
-
Neoplasms, Multiple Primary / pathology*
-
Organoplatinum Compounds / administration & dosage
-
Oxaliplatin
-
Pancreatic Neoplasms / drug therapy
-
Pancreatic Neoplasms / pathology*
-
Rare Diseases / drug therapy
-
Rare Diseases / pathology
-
Stomach Neoplasms / drug therapy
-
Stomach Neoplasms / pathology*
-
Tomography, X-Ray Computed
Substances
-
Organoplatinum Compounds
-
Oxaliplatin
-
Irinotecan
-
Fluorouracil
-
Camptothecin